Scenarios that move QDEL
QuidelOrtho Corporation - Common Stock
Scenarios that move QDEL: 1 analysis, 1 positive, 0 negative.
- · argenx meets primary endpoint in Phase II celiac disease study — ▲ · impact +8 · confidence low · horizon quarters
QuidelOrtho Corporation - Common Stock
Scenarios that move QDEL: 1 analysis, 1 positive, 0 negative.